Screener
Evolent Health, Inc. EVH Net Change in Cash
Net Change in Cash at other companies
Other financials
Where this comes from
Reported directly by Evolent Health, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect.
The source filing: Evolent Health, Inc.’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 8:53 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628908-26-000086
| Line item | For the Six Months Ended June 30, 2026 | For the Six Months Ended June 30, 2025 |
|---|---|---|
| Repayment of debt | (10,000) | (62,500) |
| Payment of preferred dividends | — | (9,198) |
| Taxes withheld and paid for vesting of equity awards | (1,823) | (4,621) |
| Net cash and restricted cash (used in) provided by financing activities | (14,966) | 98,927 |
| Effect of exchange rate on cash and cash equivalents and restricted cash | (863) | (60) |
| Net decrease in cash and cash equivalents and restricted cash | (39,230) | (526) |
| Cash and cash equivalents and restricted cash as of beginning-of-period | 180,696 | 178,496 |
| Cash and cash equivalents and restricted cash as of end-of-period | $141,466 | $177,970 |
Item 1. Financial Statements
FAQ
- What is Evolent Health, Inc.'s net change in cash?
- Evolent Health, Inc. (EVH) reported net change in cash of -$27.28M in Q2 2026.
- How has Evolent Health, Inc.'s net change in cash changed year-over-year?
- Evolent Health, Inc.'s net change in cash increased by 72.7% year-over-year, from -$99.88M to -$27.28M.
- What does net change in cash mean?
- Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.
Ask your AI about Evolent Health, Inc.'s net change in cash.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude